Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
1.440
+0.050 (3.60%)
At close: Dec 20, 2024, 4:00 PM
1.410
-0.030 (-2.08%)
After-hours: Dec 20, 2024, 5:00 PM EST

Outlook Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 2018 - 2014
Net Income
-94.05-58.98-66.05-53.16-35.24-34.52
Upgrade
Depreciation & Amortization
0.10.040.20.260.553.36
Upgrade
Asset Writedown & Restructuring Costs
----0.5311.27
Upgrade
Loss (Gain) on Equity Investments
0.090.010.050.05--
Upgrade
Stock-Based Compensation
5.375.557.714.892.811.31
Upgrade
Other Operating Activities
33.165.653.10.790.83-0.52
Upgrade
Change in Accounts Payable
0.623.081.3-0.2-1.49-1.33
Upgrade
Change in Unearned Revenue
------8.15
Upgrade
Change in Income Taxes
-----00
Upgrade
Change in Other Net Operating Assets
-9.851.67-2.98-6.880.22-3.72
Upgrade
Operating Cash Flow
-64.55-42.97-56.67-54.25-31.79-32.29
Upgrade
Capital Expenditures
------0.44
Upgrade
Investment in Securities
-----0.9-
Upgrade
Investing Cash Flow
-----0.9-0.44
Upgrade
Long-Term Debt Issued
-3010100.9-
Upgrade
Long-Term Debt Repaid
--10.23-12.32-3.69-0.26-6.94
Upgrade
Net Debt Issued (Repaid)
-0.0119.77-2.326.310.64-6.94
Upgrade
Issuance of Common Stock
62.8830.0262.5149.936.5745.97
Upgrade
Other Financing Activities
--0.82-0.6-0.01--
Upgrade
Financing Cash Flow
62.8748.9759.5956.1937.2139.03
Upgrade
Net Cash Flow
-1.6862.921.944.526.3
Upgrade
Free Cash Flow
-64.55-42.97-56.67-54.25-31.79-32.73
Upgrade
Free Cash Flow Margin
------401.75%
Upgrade
Free Cash Flow Per Share
-4.07-3.44-5.34-7.11-8.76-35.98
Upgrade
Cash Interest Paid
0.481.161.560.050.912.79
Upgrade
Levered Free Cash Flow
-43.59-23.65-32.53-35.62-17.11-22.38
Upgrade
Unlevered Free Cash Flow
-42.22-22.68-31.6-35.03-16.01-20.21
Upgrade
Change in Net Working Capital
9.38-4.940.17.85-3.338.8
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.